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Early diagnosis of melanoma leads to the best prognosis for
patients andmaybemore likely achievedwhen thosewhoare
at high risk for melanoma undergo regular and systematic
monitoring. However, many people rarely or never see a der-
matologist. Risk prediction
models (recently reviewedby
Usher-Smith et al1) could as-
sist to triage people into pre-
ventive care appropriate for their risk profile. Most risk
prediction models contain measures of phenotype including
skin, eye, and hair color as well as genetic mutations. Almost
all risk predictionmodels also contain the number and size of
nevi, aswell as thepresenceofneviwith atypical features that
are independently associated with melanoma risk. In the ab-
senceof formalpopulation-basedscreeningprogramsformela-
noma in most countries worldwide, people with high-risk
phenotypesmay need to consider regular monitoring or self-
monitoringof theirnevi,2 especially sincemostmelanomasare
self-detected or found by a friend or relative. Another group
ofpatients thatwill require regularmonitoringarepatientswho
havebeensuccessfully treated for their firstmelanoma,whose
risk to develop a secondmelanoma is greatly increased.3,4 In
a US study of 89 515melanoma survivors, those with a previ-
ous diagnosis of melanoma had a 9-fold increased risk of de-
veloping subsequent melanoma compared with the general
population, equating to a rate of 3.76 per 1000 person-years,3
while inanAustralian study, riskof subsequentmelanomawas
6 per 1000 person-years.5 Regular follow-up is therefore es-
sential formelanomasurvivors, especially during the first few
years after initial melanoma diagnosis.
Recommendations for follow-up frequency vary be-
tweendifferent setsof international guidelines,with somerec-
ommendingaphysicianvisit every3months.6Thisplaces con-
siderable burden on patients and strain on clinicians and the
health care system.Strategies forminimizing this burdenhave
been explored in recent years, with researchers and clini-
cians investigating alternativemodels of care and the integra-
tion of self-examination into skin cancer monitoring. For ex-
ample, moving follow-up from specialized melanoma clinics
to family physicians has been tested in trials in the United
Kingdom,7andstudieshavebegun investigating theroleofmo-
bile consumer teledermoscopy. Most guidelines for mela-
nomaprevention and follow-up recommend that people con-
duct regular skin self-examinations.Although there is limited
support for the sensitivity of skin self-examination,8 a num-
berof studieshave reported that themajorityof initial andsub-
sequent second melanomas are found by the patients them-
selves or their partners,9 especially among young people.10
Exploring the feasibility and predictors of adherence and
thoroughness of skin self-examination may help to design
interventions to maximize the effectiveness of this method
for melanoma detection or follow-up in future.
The study by Wu and colleagues11 in this issue adds sig-
nificantly to the discussion on whether regular follow-up
visits with clinicians could be replaced by patient self-
monitoringwith remote feedback by a teledermatologist. Es-
sentially mobile teledermoscopy combines self-examination
with specialist diagnosis. Wu et al11 enrolled and followed up
29patients,whowere asked to specificallymonitor 1 or 2 nevi
by their dermatologist. To do so, the patients used a mobile
teledermoscope to image these nevi, whichwere then sent to
a teledermatologist for diagnosis. Comparedwith the clinical
assessment of these nevi by a dermatologist (25were deemed
unchangedand4changed), the teledermatologist agreedwith
all of the clinical recommendations but opted for amore con-
servative diagnosis for 1 lesion, resulting in a kappa score of
0.87.Thepatientsweresatisfiedwith theprocess,which is con-
sistentwith earlier reports of patient satisfactionwith teleder-
moscopy servicesbyEbner andcolleagues.12However, inboth
studies the service was somewhat artificial, with all mobile
teledermoscopyprocedures conducted in theclinic settingun-
der the watchful eyes of a research assistant.
Recent results of other small studies indicate that people
are just as likely to send clinically evaluable pictures if they
usemobile teledermoscopyathomeintheirprivacy.13Thiscon-
trastswith less favorable results fromastudy that aimed to in-
tegrate teledermoscopy intoprimarycare,placingtheburdenof
picture taking and communication with the teledermatolo-
gists on the primary care providers. The family physicians re-
ported many barriers including issues with the internet con-
nectivity, lengthening of the consultation times, and the
consultation covering several topics and not just nevi
diagnoses.14 A New Zealand study examined a hybridmodel,
wherebypatientswent toanurse-staffedvirtual clinic for their
clinical and dermoscopic pictures to be taken and sent to
teledermatologist.15 Interestingly, only36%of thevirtual clinic
patients were recommended treatment compared with pa-
tients in the face-to-face clinic (60%), potentially as a result
of the absence of full-body examination at the virtual clinic.
Alternatively, specificity may have been improved using
mobile teledermoscopy and could save unnecessary proce-
dures. The virtual clinicmodel reducedwaiting times signifi-
cantly, savedcosts, andwaspreferredby themajorityofpeople
whowereassigned to it.Thisbriefdiscussionofpotentialmod-
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els of teledermoscopyuse resonateswith the summary byHo
et al16 of the major areas for consideration to allow effective
integration of such patient services into standard practice.
These include (1) technical specifications, (2) user experience
and workflow, and (3) integration and scalability.16
In conclusion, the findings fromWuand colleagues11 pro-
vide further support for the feasibilityof consumer-drivenmo-
bile teledermoscopy.Most studies to date have been small pi-
lot cohort studies or trials, and larger studies with longer
follow-up involvinga representativegroupofpatients, includ-
ing thosewith little technical skills, areneeded toascertain the
viability of suchpractices. Such studies should also be accom-
paniedby robust health economics assessments and incorpo-
rate a description of the business models that will allow der-
matologists to run such serviceswithin their practices reliably
and cost effectively.
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